ORLANDO – Was December just a bit of holiday indulgence for the generic industry, or were the end-of-year submissions the beginning of a trend that could fuel friction between industry and FDA?
FDA's Office of Generic Drugs Director Kathleen Uhl didn't address the question at the Generic Pharmaceutical Association's annual meeting on...